Primary Hyperparathyroidism in MEN-1 Syndrome
Author Information
Author(s): Grzegorz Piecha, Jerzy Chudek, Andrzej Więcek
Primary Institution: Medical University of Silesia
Hypothesis
Primary hyperparathyroidism may occur as part of an inherited syndrome known as Multiple Endocrine Neoplasia type 1 (MEN-1).
Conclusion
The diagnosis of MEN-1-associated primary hyperparathyroidism should be confirmed by genetic testing, and surgery remains the main method of management despite a high recurrence rate.
Supporting Evidence
- Primary hyperparathyroidism is the most frequent clinical presentation of MEN-1, appearing usually in the second decade of life.
- About 90% of MEN-1 mutation carriers present with primary hyperparathyroidism.
- Regular screening for hyperparathyroidism is recommended every 1–3 years for MEN-1 mutation carriers.
Takeaway
Some people inherit a condition called MEN-1 that can cause problems with their parathyroid glands, leading to high calcium levels and other health issues. Doctors recommend regular check-ups and sometimes surgery to help manage these problems.
Methodology
The paper reviews the pathomechanism, screening procedures, diagnosis, and management of primary hyperparathyroidism in MEN-1 syndrome.
Limitations
Routine testing for MEN-1 mutations is not recommended for all young patients with primary hyperparathyroidism due to the rarity of these mutations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website